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Key points 
 Patients with renal failure undergoing maintenance haemodialysis are associated with insulin 
resistance and protein metabolism dysfunction. 
 Novel research suggests that disruption to the transmembrane protein linkage between the 
cytoskeleton and the extracellular matrix in skeletal muscle may contribute to reduced amino 
acid metabolism and insulin resistance in haemodialysis. 
 ILK, PINCH1 and pFAKTyr397 were significantly decreased in haemodialysis compared to 
controls, whereas Rac1 and Akt2 showed no different between groups. 
 Rac1 deletion in the Rac1 knockout model did not alter the expression of integrin-associated 
proteins. 
 Phenylalanine kinetics were reduced in the haemodialysis group at 30 and 60 min post meal 
ingestion compared to controls; both groups showed similar levels of insulin sensitivity and 
β-cell function. 
 Key proteins in the integrin–cytoskeleton linkage are reduced in haemodialysis patients, 
suggesting for the first time that integrin-associated proteins dysfunction may contribute 
to reduced phenylalanine flux without affecting insulin resistance in haemodialysis patients. 
Dr Draicchio has a background in Biotechnology before moving into the research theme of Human 
Metabolism and metabolic disorders of type 2 diabetes and chronic kidney disease in the Laboratory of 
Dr Richard Mackenzie in collaboration with Dr Nick Burd. Her research suggests that disruption to the 
transmembrane protein linkage between the cytoskeleton and the extracellular matrix in skeletal muscle 
may contribute to reduced amino acid metabolism and insulin resistance in hemodialysis. Richard 
W.A. Mackenzie is a Reader in Insulin Resistance and Metabolism at the University of Roehampton 
(London). With over 10 years’ experience in investigating the mechanisms that govern contraction- and 
insulin-stimulated glucose transport in skeletal muscle, he has a particular interest in the role of inositol 
hexakisphosphate (IP6) kinase 1 (IP6K1) in the inhibition Akt/PKB and reduced insulin signalling in 
skeletal muscle. His research focus requires molecular and whole-body approaches to investigate the 
disease processes in human metabolism and type 2 diabetes. 
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Abstract Muscle atrophy, insulin resistance and reduced muscle phosphoinositide 3-kinase-Akt 
signalling are common characteristics of patients undergoing maintenance haemodialysis (MHD). 
Disruption to the transmembrane protein linkage between the cytoskeleton and the extracellular 
matrix in skeletal muscle may contribute to reduced amino acid metabolism and insulin resistance 
in MHD patients. Eight MHD patients (age: 56 ± 5 years: body mass index: 32  ± 2 kg m–2) 
and non-diseased controls (age: 50 ± 2 years: body mass index: 31  ± 1 kg m–2) received  
primed continuous L-[ring-2H5]phenylalanine before consuming a mixed meal. Phenylalanine 
metabolism was determined using two-compartment modelling. Muscle biopsies were collected 
prior to the meal and at 300 min postprandially. In a separate experiment, skeletal muscle tissue 
from muscle-specific Rac1 knockout (Rac1 mKO) was harvested to investigate whether Rac1 
depletion disrupted the cytoskeleton-integrin linkage, allowing for cross-model examination of 
proteins of interest. ILK, PINCH1 and pFAKTyr397 were significantly lower in MHD (P < 0.01). 
Rac1 and Akt showed no difference between groups for the human trial. Rac1 deletion in the 
Rac1 mKO model did not alter the expression of integrin-associated proteins. Phenylalanine rates 
of appearance and disappearance, as well as metabolic clearance rates, were lower in the MHD 
group at 30 and 60 min post meal ingestion compared to controls (P < 0.05). Both groups showed 
similar levels of insulin sensitivity and β-cell function. Key proteins in the integrin–cytoskeleton 
linkage are reduced in MHD patients, suggesting for the first time that integrin-associated proteins 
dysfunction may contribute to reduced phenylalanine flux without affecting insulin resistance in 
haemodialysis patients. 
(Received 3 July 2020; accepted after revision 9 September 2020; first published online 24 September 2020) 
Corresponding author R. Mackenzie: Department of Life Sciences, Sport and Exercise Science Research Centre, 
Whitelands College, University of Roehampton, 1076 Parkstead House, London SW15 4JD, UK. 
Email: richard.mackenzie@roehampton.ac.uk 
Introduction the tension-mediated pathway (Chambers et al. 2009; 
Jensen et al. 2014; Sylow et al. 2015). It is hypo-
Patients with renal failure undergoing maintenance thesized that this latter pathway requires a structurally 
haemodialysis (MHD) demonstrate several metabolic stable linkage between the extracellular matrix and 
and phenotypic alterations including muscle wasting the actin–cytoskeleton to encourage normal nutrient 
(Workeneh & Mitch, 2010; van Vliet et al. 2018) as uptake. 
a result of increased degradation of muscle proteins The dystroglycan complex and integrins are major
through activation of the ubiquitin-proteasome system surface receptors of the extracellular matrix (ECM) in 
(Workeneh & Mitch, 2010). Decreased muscle mass skeletal muscles (Von der Mark et al. 1991; Hynes, 
results in decreased motor function and glucose 2002; Postel et al. 2008; Williams et al. 2015). Integrins 
storage capacity (Johansen et al. 2003). Using the are transmembrane proteins formed by α and β sub-
‘gold standard’ euglycaemic-hyperinsulinemic clamp, units, which mediate interactions between the ECM and 
DeFronzo et al. (1981) showed that patients with renal the cytoplasmic cytoskeleton (Postel et al. 2008), and 
failure demonstrated insulin resistance, a finding that they are responsible for transducing signals across the 
is supported elsewhere (Kobayashi et al. 2005; Bailey membrane to the intracellular integrin-binding proteins 
et al. 2006; Semenkovich, 2006; Turcotte & Fisher, 2008; (Williams et al. 2015; Kang et al. 2016). Although the 
Thomas et al. 2015). role of integrins in ECM and muscle cell integrity has 
Glucose transport into skeletal muscle is known to been extensively characterized (Legate & Fässler, 2009; 
occur via two distinct pathways: (i) insulin-mediated Wickström et al. 2010), little is known about the function 
GLUT4 translocation, partly requiring functional of the integrin-binding intracellular complexes in both 
IRS-1-Akt/AS160 signalling (Deshmukh, 2016), and mechanical stability (Postel et al. 2008; Wickström et al. 
(ii) contraction-stimulated GLUT4 movement via 2010) and normal nutrient metabolism in skeletal muscle. 
Ca+2-dependent AMPK/AS160 signalling (Wright et al. Once activated, the integrin complex stimulates down-
2005; Kramer et al. 2006; Mackenzie & Elliott, 2014; stream targets implicated in both insulin-like growth 
Sylow et al. 2017). Of note, it is widely accepted that it factor and insulin receptor substrate signalling, including 
is the first pathway that is defective in insulin resistant integrin-linked kinase (ILK), focal adhesion kinase 
skeletal muscle. More recently, a third pathway that (FAK), serine/threonine-specific protein kinase (Akt),
facilities glucose transport has been identified, termed Rho GTPase Rac1 and glycogen synthase kinase 3β 
C 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society 
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(GSK-3β) (Williams et al. 2015). Thus, integrin and its 
associated target kinases appear to be implicated in muscle 
protein synthesis (Byun et al. 2012; Clemente et al. 2012), 
insulin-mediated glucose uptake (Huang et al. 2006; Bisht 
et al. 2007; Bisht & Dey, 2008) and cytoskeletal stabilization 
(Williams et al. 2015). 
Muscle atrophy, a recognized characteristic of MHD 
(van Vliet et al. 2018), has been linked with reduced 
muscle integrin-associated protein content (Pattison et al. 
2004; Postel et al. 2008; Wang et al. 2008; Peter 
et al. 2011). In addition, reduced integrin-associated 
protein expression is also noted in insulin resistance 
with decreased Akt phosphorylation, a candidate for 
reduced insulin-mediated glucose (Urso et al. 2006). 
Given that kidney failure patients display signs of 
muscle atrophy (Workeneh & Mitch, 2010; van Vliet 
et al. 2018), we hypothesized that MHD patients would 
demonstrate reduced integrin-associated protein content 
in skeletal muscle compared to non-MHD individuals. 
We further hypothesized that the structural and signalling 
disruption might lead to impaired regulation of protein 
metabolism and nutrient flux. The present study used 
two compartment whole-body measures of phenylalanine 
kinetics and surrogate measures of insulin resistance to 
partly test this hypothesis. 
Rac1 is a well characterized member of Rho GTPase 
family and is implicated in cytoskeletal reorganization, 
transcriptional regulation, cell migration and nutrient 
uptake (Burridge & Wennerberg, 2004; Ueda et al. 
2008). Rac1 is known to promote GLUT4 translocation 
and glucose uptake via mechanisms requiring actin 
remodelling in skeletal muscle (T¨ ok et al. 2004; JeBailey or¨
et al. 2007; Sylow et al. 2013b). Thus, proteins involved 
in vesicle trafficking may only operate fully in the pre-
sence of a functional cytoskeleton (Ueda et al. 2008). The 
ILK PINCH parvin (IPP) complex functions at one of the 
early steps of the integrin signalling cascade (Wu, 1999; 
Stanchi et al. 2009). The pseudokinase integrin-linked 
kinase ILK recruits downstream targets implicated in 
insulin-mediated glucose uptake and links integrins to 
the actin cytoskeleton (Gheyara et al. 2007); among 
its downstream targets, there are PDK1 and GSK-3β 
(through PINCH1), as well as α-actinin and Rac1 (through 
parvin) (Williams et al. 2015). ILK directly interacts 
with the β-integrin subunits and is stimulated by both 
integrin activation and growth factors and appears to 
act as an upstream regulator of Akt (Wu & Dedhar, 
2001; Tang et al. 2007). Therefore, this integrin signalling 
pathway is suggested to facilitate glucose uptake via both 
insulin-dependent and independent mechanisms in a 
cross-sarcolemma fashion. 
Accordingly, in the present study, we probed skeletal 
muscle from insulin resistant, but otherwise healthy 
controls, and made comparisons with MHD patients in 
both a fasted and postprandial state for integrin-associated 
protein signalling. Using an established muscle-specific 
Rac1 knockout rodent model (Sylow et al. 2013a; 
Raun et al. 2018), a secondary aim was to investigate 




Ethics for human experiments was approved by 
the local Ethics Board (University of Illinois at 
Urbana-Champaign) and met all conditions outlined in 
the seventh revision of the Declaration of Helsinki for use 
of human volunteers (Clinical Trial Registration Number: 
NCT03478722). 
All experiments regarding the mouse models 
were approved by the Danish Animal Experimental 
Inspectorate (License: 2016-15-0201-0 1043). 
Human experiment 
Eight MHD patients [mean ± SEM age 56 ± 5 years,  
male sex = 6 (75%), body mass index = 32 ± 2 kg m–2, 
body fat = 31 ± 3%, homeostatic model assessment 
of insulin resistance (HOMAIR) = 3.9 ± 0.9 and 
HOMAβ-cell = 4.3 ± 1.24] and eight matched insulin 
resistant controls [age 50 ± 2 years, male sex = 6 (75%), 
body mass index = 31 ± 1 kg m–2, body fat  = 29 ± 2%, 
HOMAIR = 4.0 ± 0.6 and HOMAβ-cell = 4.8 ± 0.65] were 
recruited for the study. These participants were part of 
a larger investigation being conducted in our laboratory. 
[HOMAIR; fasting  insulin (μU mL−1) × fasting glucose 
(mmol L–1)/22.5] and HOMA of β-cell function 
[HOMAβ-Cell; 20  × fasting insulin (μU mL−1)/fasting 
glucose – 3.5 (mmol L−1)] were calculated using validated 
equations (Uwaifo et al. 2002). Volunteers received 
written and verbal details on the experimental design, 
the study aims and potential risks before providing 
their written consent. For MHD patients, we requested 
physician clearance from their nephrologist to further that 
ensure it was safe for the patient to participate in the study. 
A full description of the pre-screening and experimental 
procedures is provided elsewhere (van Vliet et al. 2018). 
The MHD patients analysed in the present study have 
been in dialysis treatment for 5 years and their current 
nutritional status comprised ingestion of protein-rich 
meals to achieve the recommended protein intakes (set 
at 1.2 g kg−1 body weight day–1) to limit muscle protein 
losses observed in end-stage kidney disease. 
MHD patients were studied 24 h after a dialysis 
treatment session (i.e. non-dialysis day). Volunteers 
ingested an identical meal (320 kcal; 22 g of protein, 
43 g of carbohydrates, 7 g of fat) at least 12 h prior 
to trials and arrived in a fasted state to the laboratory 
C 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society 
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at 07.00 h. An 18-gauge cannula was positioned into a 
dorsal hand vein to allow frequent sampling of arterialized 
blood (every 30–60 min) with a thermoregulated hot box 
(65°C). A second 18-gauge cannula was placed into 
an antecubital vein for the primed constant infusion of 
L-[ring-2H5]phenylalanine (prime; 2.0 μmol kg−1 free fat 
mass, infusion rate; 0.05 μmol kg−1 free fat mass min−1). 
A baseline blood sample was collected at t = −180 min 
immediately prior to the start of the infusion protocol. 
Muscle biopsies were collected at t = −120 and −0 min  of  
the infusion, reflecting a post-absorptive state. 
Subsequently, volunteer ingested a mixed meal 
(546 kcal; 20 g of protein, 59 g of carbohydrates, 26 g 
of fat), the completion of which marked the start of the 
postprandial phase (t = 0 min). An additional muscle 
biopsy was collected at 300 min. Biopsies were sampled 
from the middle region of the vastus lateralis (15 cm above 
the patella) with a Bergström needle modified for suction 
under local anaesthesia (2% lidocaine) (van Vliet et al. 
2018). The post-absorptive muscle biopsies were sampled 
from the same incision with the needle pointed in the 
distal and proximal directions, respectively (van Vliet et al. 
2018). Muscle samples were immediately frozen in liquid 
nitrogen  and stored at  −80°C until subsequent analysis. 
Blood samples were centrifuged at 3000 g for 10 min 
at 4°C and plasma was stored at –80°C for subsequent 
analysis. 
Mouse models 
Considering the importance of an intact cytoskeleton for 
normal glucose uptake in skeletal muscles, we aimed to 
investigate the potential role of the major actin regulators, 
Rac1, in the integrin signalling pathway. Thus, nine 
muscle specific tetracycline-inducible knockout (mKO) 
mice and seven control mice were analysed in the pre-
sent study. A full description of the Rac1 muscle-specific 
tetracycline-inducible knockout (mKO) mouse model 
used in this experiment is provided elsewhere (Sylow et al. 
2013b, 2013a). Skeletal muscle from Rac1 mKO mice 
were analysed when the mice were 31–33 weeks of age. 
Rac1 mKO was induced at 12–16 weeks of age by adding 
doxycycline (a tetracycline analogue) in the drinking water 
(1 g L−1; Sigma Aldrich, Copenhagen, Denmark) for 
3 weeks to deplete Rac1 specifically in skeletal muscle 
(PMID: 29 749 029). This treatment was repeated at week 
10 of the intervention period to ensure continuous Rac1 
knockout throughout the entire intervention period. An 
18-week diet intervention was started at 14–18 weeks of 
age and mice received either a standard rodent chow diet 
(Altromin no. 1324; Brogaarden, Horsholm, Denmark) 
or a 60% high-fat diet (HFD) (no. D12492; Brogaarden) 
and water ad lib. Body weight was assessed every week. 
In the present study, we investigated skeletal muscles 
of chow-fed mice. All animals were maintained under 
a 12:12 h light/dark photocycle, and group housed at 
20–21°C. For muscle tissue sampling, mice were fasted 
for 3–5 h from 07.00 h and anaesthetized (I.P. injection  
of 7.5/9.5 mg (chow/HFD) pentobarbital sodium 100 g−1 
body weight). After 25 min, skeletal muscle was excised 
and quickly  frozen  in  liquid  nitrogen  and stored at –80°C 
until processing. 
Immunoblotting 
Relative total muscle protein content and phosphorylation 
levels of relevant proteins were determined by standard 
immunoblotting techniques loading equal amounts of 
protein. The primary antibodies used were anti-Integrin 
linked ILK antibody (ab227154; Abcam, Cambridge, 
MA, USA), anti-PINCH1 antibody [EP1943Y] (ab76112; 
Abcam), α-parvin (D7F9) XP Rabbit mAb (8190S; 
Cell Signaling Technology, Beverly, MA, USA) (37), 
pFAKTyr397 (D20B1) Rabbit mAb (8556S; Cell Signaling 
Technology) (Tuguzbaeva et al. 2019), anti-total FAK 
(ab40794; Abcam) (Bian et al. 2019), anti-Rac1 (ARC03; 
Cytoskeleton Inc., Denver, CO, USA) (Raun et al. 2018), 
anti-total Akt2 (no. 3063; Cell Signaling Technology) 
(Raun et al. 2018), pAktS473 (no. 9271; Cell Signaling 
Technology) (Karusheva et al. 2019), pAktT308 (no. 9275; 
Cell Signaling Technology) (Raun et al. 2018), anti-IP6K1 
antibody (ab129595; Abcam) and anti-dystrophin 
(ab15277; Abcam) (Jelinkova et al. 2019). 
Polyvinylidene difluoride membranes (Immobilon 
TransferMembrane; Millipore, Burlington, MA, USA) 
were blocked in Tris-buffered saline-Tween 20 containing 
2% skimmed milk or 5% BSA protein for 30–60 min 
at room temperature. Membranes were incubated with 
primary antibodies overnight at 4°C, followed by 
incubation with rabbit or mouse peroxidase-conjugated 
secondary antibody for 30 min at room temperature. 
Coomassie brilliant blue staining was used as a loading 
control (Welinder & Ekblad, 2011). Bands were visualized 
using the ChemiDoc MP Imaging System (Bio-Rad, 
Hercules, CA, USA). Raw data for all the above 
protein analysed are openly available via figshare: 
https://doi.org/10.6084/m9.figshare.12886943. 
Blood analysis 
Blood metabolites were determined using a point-of-care 
chemistry analyser (Piccolo Xpress Chemistry 
Analyzer; Abaxis, Union City, CA, USA). Plasma 
insulin concentrations were determined using a 
commercially available enzyme-linked immuno-
sorbent assays (Alpco Diagnostics, Salem, NH, USA). 
Plasma phenylalanine concentrations (unlabelled) and 
phenylalanine enrichments (labelled) were determined 
by gas chromatography-mass spectrometry analysis 
(Agilent 7890A GC/5975C; MSD, Little Falls, DE, USA) 
C 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society 
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as described previously (van Vliet et al. 2016). Briefly, 
plasma samples were prepared for amino acid analysis 
using a mixture of isopropanol:acetonitrile:water (3:3:2, 
v/v) and centrifuged at 20 000 g for 10 min at 4°C. 
Subsequently, the supernatant was dried, and the amino 
acids converted into tert-butyldimethylsilyl derivatives 
prior to gas chromatography-mass spectrometry 
analysis. L-[ring-2H5]phenylalanine, m/z 336 (m+0) and 
341 (m+5) were monitored for unlabelled and labelled 
phenylalanine, respectively. 
Data modelling 
Plasma insulin and endogenous glucose concentrations 
were used to model the measures of insulin sensitivity 
(ISI) (Matsuda index) (Matsuda & Defronzo, 1999): acute 
insulin response to glucose (AIRg), second phase insulin 
response ( I60–120/ G60–120) (Lorenzo  et al. 2013) and 
disposition index (DI = SI × AIRg) (Utzschneider et al. 
2009). 
Whole body phenylalanine rate of disappearance 
(Rd), rate of appearance (Ra) and metabolic clearance 
rates (MCR values) were calculated as described pre-
viously (Bergman et al. 1989; Gastaldelli et al. 1999; 
Barclay et al. 2020). Raw data for insulin and 
phenylalanine metabolism are openly available via 
figshare: https://doi.org/10.6084/m9.figshare.12886943. 
Statistical analysis 
R software (R Foundation for Statistical Computing, 
Viena, Austria) and the Lme4 package (Bates et al. 2015) 
were used to perform linear mixed effects analyses of the 
relationship between insulin, phenylalanine or protein 
values, and time and condition (controls and MHD). 
Condition interacting with time was entered as a fixed 
effect into the model, whereas the main effects of subjects 
and time were considered as the random effects. If the null 
hypothesis was rejected, post hoc tests were performed to 
determine which groups differed from each other. P < 0.05 
was considered statistically significant. 
Results 
ISI 
HOMAIR and HOMAβ-Cell (P > 0.05) were comparable 
between groups, suggesting no difference metabolic 
dysfunction between MHD and non-MHD individuals 
(data not shown). Estimations of ISI and β-cell function 
based on the 59 g of oral carbohydrate load are shown 
in Fig. 1. These data show that there were no significant 
differences for ISI (P = 0.3948) (Fig. 1A). β-cell function 
was also similar between groups with AIRg (P = 0.2006) 
(Fig. 1B), second phase insulin response to oral glucose 
(P = 0.8286) (Fig. 1C) or DI (P = 0.5605) (Fig. 1D), 
showing no difference at 2 h after feeding. 
Whole-body protein metabolism was estimated using 
L-[ring-2H5]phenylalanine to allow for the calculations 
of phenylalanine Ra, Rd and MCR (Fig. 2) from time 
0 to 300 min of the postprandial period. The MHD 
group showed a significant decrease in Ra, (P = 0.0451 
at 30 min, P = 0.0131 at 60 min; P = 0.0002 at 90 min and 
P = 0.0015 at 300 min) (Fig. 2A and B), Rd (P = 0.0007 
at 30 min, P = 0.0022 at 60 min; P = 0.0003 at 90 min 
and P = 0.00141 at 300 min) (Fig. 2C and D) and  MCR  
(P = 0.0021 at 30 min; P = 0.0025 at 60 min; P = 0.0001 
at 90 min and P = 0.0003 at 300 min) (Fig. 2E and F) in  
the 300 min after feeding that, overall, was not apparent 
for the control group. In the controls, Ra, (P = 0.9664 at 
30 min; P = 0.9933 at 60 min; P = 0.1129 at 90 min and 
P = 0.2512 at 300) (Fig. 2A and B) and  Rd (P = 0.6071 
at 30 min; P = 0.3175 at 60 min; P = 0.1523 at 90 min 
and P = 0.903 at 300 min) (Fig. 2C and D) did  not show  
relevant changes after feeding, whereas MCR (Fig. 2E and 
F) only showed a decrease at 90 min (P = 0.0247) and 
300 min (P = 0.0252), but not at 30 min (P = 0.7865) or 
60 min (P = 0.6762).There were significantly differences 
at 30 min for Rd (P = 0.0476) and MCR (P = 0.0345), but 
not for Ra (P = 0.1595), between groups. 
Both Ra (P = 0.0501) and Rd (P = 0.0402) were 
significantly different at 60 min, whereas MCR expressed 
a tendency to be different (P = 0.0695). Similar trends 
between groups were observed at 90 min (Ra, P = 0.2539; 
Rd, P = 0.4363; MCR, P = 0.1637) and 300 min (Ra, 
P = 0.2977; Rd, P = 0.415; MCR, P = 0.4043). 
Human skeletal muscle analysis 
We investigated total and phosphorylated states of 
proteins implicated in the integrin signalling cascade, as 
well as those involved in the insulin-dependent pathway in 
eight MHD patients and eight controls. From the western 
blot analyses, ILK (Fig. 3A) and PINCH1 protein content 
(Fig. 3B), proxy indicators of integrin signalling activity, 
were significantly reduced in the MHD patients compared 
to the controls in both the fasted (P = 0.0133 and 
P = 0.0001, respectively) and postprandial (P = 0.0001 
pFAKTyr397/tFAK and P = 0.0001, respectively) state. 
(Fig. 3D) was also reduced in MHD; however, statistical 
analyses revealed a significant decrease in the fasted state 
(P = 0.0026), but not in the postprandial (P = 0.1164) 
state. The actin cytoskeleton regulating protein Rac1 was 
not different in MHD compared to control (P = 0.5783 
and P = 0.3024 in the fasted and postprandial states, 
respectively) (Fig. 3E). Representative blots are shown 
in Fig. 3H. No difference was noted for either Akt2 
(P = 0.8552 and P = 0.2496 in the fasted and postprandial 
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states, respectively) (Fig. 4A) or IP6K1 (P = 0.4544 
and P = 0.2759 in the fasted and postprandial states, 
respectively) (Fig. 4B) between groups. Representative 
blots are  shown in Fig. 4C. Parvin (P = 0.6778 fasted 
and P = 0.2886 postprandially) (Fig. 4C), total FAK 
(P = 0.3963 fasted and P = 0.6549 postprandially) 
(Fig. 4E) and dystrophin (P = 0.3091 fasted and P = 0.437 
postprandially) (Fig. 4G) were similar between groups. No 
bands were detected for phosphorylation targets at AktS473 
or AktT308 in control or in MHD skeletal muscles (data 
not shown). No significant differences were observed in 
protein content between fasted and postprandial state 
for ILK (P = 0.1742 for MHD and P = 0.5391 for 
controls) (Fig. 3A), PINCH1 (P = 0.5384 for MHD and 
P = 0.2276 for controls) (Fig. 3B), parvin (P = 0.6804 
for MHD and P = 0.4003 for controls) (Fig. 3C), 
pFAKTyr397(P = 0.9352 for MHD and P = 0.2554 for 
controls) (Fig. 3D), dystrophin (P = 0.1533 for MHD and 
P = 0.1324 for controls, Fig. 3G) or IP6K1 (P = 0.7282 
for MHD and P = 0.0783 for controls) (Fig. 4B), except 
for total FAK and Rac1, which resulted significantly 
decrease post meal ingestion in controls [P = 0.0342 
(Fig. 3E) and  P = 0.033 (Fig. 3F), respectively], but not in 
the MHD (P = 0.0551 and P = 0.052, respectively) and 
total Akt2 that resulted reduced post meal in the MHD 
group (P = 0.0051) (Fig. 4A), but not in the controls 
(P = 0.0693). 
A 
Rac1 mKO mouse muscle analysis 
In a separate experiment, skeletal muscle from nine 
muscle-specific Rac1 knockout (Rac1 mKO) and seven 
wild-types was analysed. Rac1 is a well-known regulator 
of the actin cytoskeleton (JeBailey et al. 2007), although it 
is unknown whether Rac1 regulates the protein expression 
of the integrin nexus and actin cytoskeleton proteins. Rac1 
deletion did not alter the expression of integrin-associated 
proteins compared to the wild-type in skeletal muscle 
[ILK, P = 0.774 (Fig. 5A); PINCH1, P = 0.0589 (Fig. 5B); 
parvin, P = 0.0696 (Fig. 5C); pFAKTyr397, P = 0.9984 
insulin-stimulated and P = 0.9116 not insulin-stimulated, 
(Fig. 5D); total FAK, P = 0.9784 (Fig. 5E)] confirming 
the results obtained in the MHD human samples, where 
Rac1 protein expression was unaltered. Also, pAktS473 
(P = 0.2496 insulin-stimulated and P = 0.9974 not 
insulin-stimulated) (Fig. 5G), pAktT308 (P = 0.8119 
insulin-stimulated and P = 0.9986 not insulin-stimulated) 
(Fig. 5H) and  total Akt2 (P = 0.857, Fig. 5I) levels were  
not altered by the lack of Rac1 as also reported previously 
(Raun et al. 2018). The activity of both pAktS473 and 
pAktT308 increased under insulin stimulation within the 
Rac1 mKO (P = 0.0551 and P = 0.0509, respectively, 
Figure 5G and H as well as within the wild type (P = 
0.0022 and P = 0.0247, respectively, Figure 5G and H) 
compared with saline. pFAKTyr397 activity was unaltered 
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Figure 1. Insulin response to glucose 
Acute insulin response to glucose (AIRg) (left) and second phase insulin response (right) (A), Matsuda index (ISI) (B) 
and disposition index (DI) (C), after mixed meal feeding in maintenance haemodialysis (MHD, n = 8) patients and 
control (n = 8) participants. No statistically signifcant differences were observed (P > 0.05). Quartiles, means and 
individual data points are shown. 
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by insulin stimulation within both groups (Rac1 mKO; P 
= 0.4904 and P = 9127; WT, Figure 5D), confirming the 
results observed in the MHD models, where a decrease in 
pFAKTyr397, together with ILK or PINCH1 did not alter 
insulin sensitivity’s levels in MHD compared to controls. 
Furthermore, IP6K1 (P = 0.3278) (Fig. 5F) and dystrophin 
(P = 0.2054) (Fig. 5L) expression was similar in both 
Rac1 mKO and wild-type. Blots in Fig. 5M and N were 
cropped from the same membrane. 
A B 
Discussion 
The present study investigated integrin-associated protein 
signalling in skeletal muscle of MHD patients. In 
addition, using a Rac1 KO insulin resistant rodent 
model, we also examined the potential role that this 
important actin–cytoskeleton regulatory protein would 
play in upstream integrin-associated signalling in skeletal 
muscle. We hypothesized that integrin-associated protein 
expression would be reduced in both MHD patients 
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Figure 2. Whole-body phenylalanine kinetics 
Whole-body phenylalanine kinetics at baseline and postprandial for both MHD and controls (MHD, n = 8 and  
controls, n = 8). Phenylalanine Ra (A and B), phenylalanine Rd (C and D) and phenylalanine MCR (E and F) at  
baseline, as well as 30, 60, 90 and 300 min post meal ingestion. A, C and E, phenylalanine trend over time of 
each individual. B, D and F, individual data points, quartiles and means. ∗Signifcant difference between MHD 
and non-MHD (P < 0.05). †Signifcant differences from time 0. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. †P < 0.05, 
††P < 0.01, †††P < 0.001. 
C 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society 
 
8 F. Draicchio and others J Physiol 00.0 
and Rac1 KO rodents. However, it was unclear from 
the literature whether a loss of the integrin-associated 
protein structure would facilitate or hinder amino 
acid metabolism and/or ISI (i.e. nutrient flux) in the 
MHD patients. Here, we show, for the first time, that 
phenylalanine flux was reduced in the period immediately 
post meal ingestion (30 and 60 min) in MHD patients 
compared to controls. In addition, we also noted a 
reduction in the integrin-associated protein expression 
(ILK and PINCH1) for the same comparison. 
A B 
0.32 fasted post meal fasted 
0.32 
0.24 
Evidence suggests that the over development of the ECM 
structure is linked to increased insulin resistance in mouse 
models (Kang et al. 2011, 2013, 2014; Williams et al. 2015) 
as a result of a proposed increase in the physical barrier to 
hormonal and nutrient transport across the sarcolemma 
(Jansson, 2007; Williams et al. 2015). In support of 
this, Williams et al. (2015) suggested that ECM protein 
accumulation within the interstitial space impedes sub-
strate transport as a result of increased diffusion distance. 
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Figure 3. Skeletal muscle protein content in insulin resistant control and MHD patients 
Skeletal muscle protein content for targets of interest in insulin resistant control and MHD patients. Content in 
the fasted state and post meal ingestion (MHD, n = 8 and controls, n = 8) of ILK (A), PINCH1 (B), parvin (C), 
pFAKTyr397/total FAK (D), total FAK (E), Rac1 (F) and dystrophin (G). Representative western blots including the 
corresponding Coomassie brilliant blue staining of the proteins of interest (H). ∗Signifcant difference between 
MHD and non-MHD. †Signifcant differences between fasted and post meal within the same group. ∗P < 0.05, 
∗∗P < 0.01, ∗∗∗P < 0.001. †P < 0.05, ††P < 0.01, †††P < 0.001. Quartiles, means and individual data points are 
shown. 
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cytoplasmic integrin-associated proteins appear to have an 
important role as effectors in integrins signalling in skeletal 
muscle, providing an essential linkage between the ECM, 
the sarcolemma and the actin–cytoskeleton (Gheyara 
et al. 2007), therefore contributing to ECM structure 
stability. Integrin-deficient mice show progressive muscle 
dystrophy after birth (Mayer et al. 1997) as a result of a 
decreased function of the myotendinous junction (MTJ), 
which gives structural stability between ECM and the 
associated myofibrils and their non-contractile structural 
proteins (Postel et al. 2008). The central component of 
the IPP complex, ILK, is recruited to the MTJ, which 
requires the presence of the ECM protein laminin, as 
well as integrin-α7 in the sarcolemma (Postel et al. 2008), 
suggesting the involvement of ILK in ECM stability. In 
line with our hypothesis, our data showed a reduction 
in integrin-associated ILK and PINCH1, suggesting that 
MHD patients may present with reduced stability in 
the extracellular matrix as a result of dysregulation of 
integrin-associated protein signalling. 
Yet the influence of a reduced integrin-associate 
protein nexus on nutrient uptake is unclear. The 
research suggests that the over development of the 
ECM and its transmembrane associated structures are 
linked to insulin resistance in mouse models (Kang 
et al. 2011, 2013, 2014; Williams et al. 2015). In 
support of this Williams et al. (2015) have shown that 
ECM protein accumulation within the interstitial space 
impedes substrate transport. Conversely, Kang et al. 
(2013) demonstrated that a reduction of ECM-associated 
glycosaminoglycan hyaluronan induced by I.V. injection  
of PEGylated recombinant hyaluronidase PH-20 led to 
a dose-dependent increase in glucose infusion rates 
and glucose clearance in mouse skeletal muscle during 
a hyperinsulinemic–euglycaemic clamp. Taken together, 
A B 





these data may suggest that an increase in protein content 
within both the interstitial space and ECM is linked 
to insulin resistance and reduced nutrient transport, 
whereas a reduction in the protein content within these 
compartments may increase nutrient uptake as a result 
of a reduction in the physical barrier between the ECM 
and the intracellular compartments. Therefore, we further 
postulated that a reduction in the integrin-associated 
nexus and a reduction in ECM structural protein 
content may result in increased phenylalanine flux and 
improved glucose handling in MHD patients during the 
post-absorptive state (Williams et al. 2015). 
Total phenylalanine rate of appearance (Ra) is a measure 
of the appearance of dietary protein-derived phenylalanine 
and that from whole body protein breakdown into 
circulation (van Vliet et al. 2018), whereas phenylalanine 
Rd and MCR reflect whole-body amino acid clearance and 
its subsequent utilization and storage to the different tissue 
compartments within the body (Matthews, 2007; Barclay 
et al. 2020). 
In the present study, we show that one-compartment 
models of the Matsuda index (ISI) and disposition index 
(DI) were similar between groups, whereas phenylalanine 
Ra, Rd and MCR rates decreased immediately after 
time 0 in MHD but not in controls, who maintained 
a more constant trend over time, suggesting that 
the haemodialysis group may suffer from decreased 
skeletal muscle amino acid uptake and utilization in 
the post-absorptive state. Moreover, phenylalanine Ra, 
Rd and MCR were also significantly lower in the period 
immediately after feeding (30 and 60 min) in the 
MHD group. Taken together, these results suggest that 
disruptions to the integrin-associate protein nexus may 
contribute to dysregulation in amino acid metabolism but 
not ISI (Fig. 1). 
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Figure 4. Skeletal muscle protein content for Akt2 and IP6K1 
Skeletal muscle protein content for Akt2 (A) and IP6K1 (B) in the fasted state and post meal ingestion (MHD, 
n = 8 and controls, n = 8). Representative western blots of the proteins of interest including the corresponding 
Coomassie brilliant blue staining, except for IP6K1 (C). No signifcant difference was noted (P > 0.05). †Signifcant 
differences between fasted and post meal within the same group. †P < 0.05, ††P < 0.01, †††P < 0.001. Quartiles, 
means and individual data points are shown. 





































10 F. Draicchio and others J Physiol 00.0 
A B C 
0.88 
0.80 
































control Rac1 mKO 













































control Rac1 mKO control Rac1 mKO control Rac1 mKO control Rac1 mKO 
H IG 



























































control Rac1 mKO control Rac1 mKO control Rac1 mKO control Rac1 mKO control Rac1 mKO 
J 


































Figure 5. Skeletal muscle protein content of targets of interest in TA muscles 
Skeletal muscle protein content of targets of interest in TA muscles of chow-fed WT (n = 7) and Rac1 mKO 
mice (n = 9). Insulin-stimulated and not insulin-stimulated (saline) samples were considered as separated groups 
for the phosphorylated proteins. Content of ILK (A), PINCH1 (B), parvin (C), pFAKTyr397/total FAK (D), total FAK 
(E), IP6K1 (F), pAktS473/total Akt2 (G), pAktT308/total Akt2 (H), total Akt2 (I) and dystrophin (J). Representative 
western blots of Rac1 including the corresponding Coomassie brilliant blue staining, confrming the effectiveness 
of knockout (K). Representative blots including the corresponding Coomassie brilliant blue staining (L). Analogous 
results were obtained in gastrocnemius mouse muscles. No signifcant difference was noted (P > 0.05). † Denotes 
signifcant differences between saline and insulin stimulation within the same group. † P<0.05, †† P<0.01, ††† 
P<0.001.Quartiles, means and individual data points are shown. 
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We have previously shown that MHD patients 
demonstrated an anabolic resistance of muscle protein 
synthesis rates after mixed meal ingestion, supporting the 
notion that MHD patients may present with dysregulation 
in amino acid flux and metabolism (van Vliet et al. 
2018). The findings from the present study suggest that 
this dysregulation in amino acid metabolism may be 
partly attributed to disruptions to the integrin-associate 
protein nexus in skeletal muscle. A decrease in the 
integrin-associated proteins may be explained by a 
separate finding that MHD patients display both increased 
basal myofibrillar protein synthesis and muscle caspase-3 
protein content (van Vliet et al. 2018). This evidence, 
together with increased basal muscle protein synthesis 
and degradation rates, may indicate that MHD muscle 
is over-stimulated and remains in a state of constant 
flux (van Vliet et al. 2018). However, it is not clear why 
phenylalanine flux is reduced in MHD patients given that 
amino acid requirements are probably increased, given 
the raised muscle protein synthesis and breakdown rates 
in this population. However, this raised turnover may be 
linked to an up-regulation in the genes regulating the 
ubiquitin proteasome pathway (Hasselgren, 1999; Lecker 
et al. 1999; Mitch et al. 1999; Bodine et al. 2001; Ikemoto 
et al. 2001; St-Amand et al. 2001; Bey et al. 2003; Stevenson 
et al. 2003; Urso et al. 2006). In addition, the reduction 
in phenylalanine flux post meal, and thus the proposed 
availability to cell demands, may partly explain why this 
population group presents with both reduced muscle mass 
(van Vliet et al. 2018) and muscle atrophy (Johansen et al. 
2003). Interestingly, van Vliet et al. (2018) also showed that 
both basal and fed-state muscle LAT1 protein content are 
decreased in MHD patients. LAT1 is an amino acid trans-
porter found in proximity of capillaries (Hodson et al. 
2018; van Vliet et al. 2018). Blood flow and capillary 
recruitment play a fundamental role in nutrient and 
hormonal delivery to muscle (Mitch et al. 1999; Williams 
et al. 2015). Therefore, a decrease in this protein in MHD 
could be a result of capillarity rarefaction in MHD skeletal 
muscles, which is linked to insulin resistance and poor 
nutrients perfusion (Mitch et al. 1999; Solomon et al. 2011; 
Bonner et al. 2013; Williams et al. 2015), a finding that 
may also have contributed to the reduced phenylalanine 
flux observed in our MHD sample. 
Several studies suggest a role of the IPP complex 
in muscle degeneration (Gheyara et al. 2007; Postel 
et al. 2008). Postel et al. (2008) showed that 
zebrafish unable to express ILK developed mechanical 
instability in skeletal muscle. In addition, ILK-KO mice 
displayed progressive muscular dystrophy, with ILK 
mutants showing displacement of FAK, dystrophin and 
α7β1D-integrin subunits (Gheyara et al. 2007). These 
results are similar to those observed in mice and humans 
lacking α7-integrin subunit, suggesting that ILK may act as 
a cytoplasmic effector of α7β1-integrin in the pathogenesis 
of muscle degeneration (Gheyara et al. 2007; Postel et al. 
2008). The adapter protein PINCH1 is known to bind with 
ILK and locates to integrin-mediated adhesion sites (Li 
et al. 2005; Stanchi et al. 2009; Karaköse et al. 2015). Several 
studies suggest a crucial role of PINCH1 in promoting 
cell adhesion, ECM assembly, muscle attachment and Akt 
activity (Wu, 1999; Eke et al. 2010; Vakaloglou & Zervas, 
2012). Genetic ablation of PINCH1 in skeletal muscle 
results in cell death at the embryonic stage in mice (Sakai 
et al. 2003; Li et al. 2005; Wickström et al. 2010). Moreover, 
the interaction between ILK and PINCH1 is necessary to 
prevent degradation of IPP complex (Fukuda et al. 2003; 
Li et al. 2005), suggesting that defects in one of these 
proteins lead to impairment of the associated kinases of 
the IPP complex, partly supported by our finding that 
showed significant reductions in the protein content of 
ILK and PINCH1 in MHD skeletal muscle. 
The inositol hexakisphosphate (IP6) kinase1 (IP6K1) 
produces the diphosphoinositol pentakisphosphate, 
which competes with phosphatidylinositol (3,4,5)-
trisphosphate with respect to binding the pleckstrin 
homology domain of Akt, preventing Akt translocation 
to the cell membrane and its phosphorylation by PDK1, 
leading to decreased muscle ISI (Naufahu et al. 2018). 
IP6K1 can therefore represent a negative feedback 
mechanism in the insulin-dependent Akt pathway, which 
has been shown to be increased in insulin resistant 
models, whereas Akt is reduced (Chakraborty et al. 2010; 
Naufahu et al. 2018). 
We further hypothesized that disruptions to the 
integrin-actin cytoskeleton linkage, largely as a result of 
impairments in the Rho GTPase Rac1, would result in 
upstream dysregulation of integrin-associated protein and 
Akt signalling in skeletal muscle, showing a decrease in 
Akt activity and an increase in IP6K1 protein, which may 
then contribute to the reduced nutrient handling in MHD 
patients. By contrast, our results showed that Rac1, as well 
as Akt2 and IP6K1, were similar in MHD muscle compared 
to insulin resistant matched controls despite differences in 
ILK and PINCH1. 
These finding give rise to two notions (i) Rac1 and Akt2 
probably do not play a major role in the development of 
insulin resistance in MHD muscle, given that MHD and 
controls present with similar levels of insulin resistance 
and muscle protein content of Rac1 and Akt2 and (ii) 
Rac1 is not essential for upstream integrin-associated 
protein regulation. In a separate experiment, we used 
a Rac1 KO rodent model to further investigate the 
role of this molecule on the integrin-associated protein 
signalling. These experiments revealed that there was 
no difference in the IPP complex protein content in 
Rac1 mKO compared to wild-type rodents. Both Rac1 
and Akt are important regulators of insulin-stimulated 
glucose transport (JeBailey et al. 2007; Ueda et al. 2010; 
Sylow et al. 2013a, 2014; Moller et al. 2019). Several 
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studies suggest that Akt2 and Rac1 bifurcate down-
stream of phosphoinositide 3-kinase (Nozaki et al. 2012; 
Satoh, 2014; Takenaka et al. 2015) into two distinct 
parallel pathways, both promoting GLUT4 trafficking and 
muscle glucose uptake in an insulin-dependent manner 
(JeBailey et al. 2007; Ueda et al. 2008, 2010; Sylow et al. 
2014; Raun et al. 2018; Moller et al. 2019), which is 
regulated via actin cytoskeleton organisation (Jaffe & Hall, 
2005; Chiu et al. 2011; Sit & Manser, 2011; Spiering 
& Hodgson, 2011; Moller et al. 2019). Our data show 
that Rac1 is not different between MHD and non-MHD 
individuals and that both display similar degrees of ISI. 
In addition, our KO Rac1 mouse model showed no 
difference in integrin-associated proteins compared to 
the wild-type. Taken together, these data suggest that 
Rac1 may not be required for effective actin-integrin 
structural stability/remodelling or nutrient flux in MHD 
skeletal muscle. However, we cannot completely rule out a 
contribution of Rac1 in these processes. We recognize that 
whole-body phenylalanine kinetics and ISI are not direct 
measures of local amino acid turnover or insulin action 
in skeletal muscle, yet it has been recognized that skeletal 
muscle is a major disposal site for amino acids (Chang 
& Goldberg, 1978) and glucose (Thiebaud et al. 1982) in 
the postprandial state. We do acknowledge the limitations 
of our measurement and admit that the inclusion of 
multiple amino acid tracers and two-compartment models 
of glucose metabolism and ISI would offer a more accurate 
measures nutrient kinetics in this population. We also 
acknowledge that we analysed small sample size groups; 
therefore, further research involving more participants is 
required to give more robustness to our findings. 
Conclusions 
In conclusion, our results suggest that neither ISI, nor 
DI appear to be different between MHD patients and 
controls in the postprandial state. This finding may be 
explained by the similar levels of Rac1 and Atk2, two 
protein kinases implicated in insulin-dependent glucose 
uptake. Phenylalanine metabolism was lower within the 
MHD group, which may be linked to disruptions to the 
ILK-PINCH1 nexus and LAT1 (van Vliet et al. 2018), 
suggesting, for the first time, that the integrin-associated 
protein network may be required for effective nutrient 
uptake in skeletal muscle. 
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I, Lacampagne A, Forte G, Dvorak P, Meli AC & Rotrekl V 
(2019). Dystrophin deficiency leads to genomic instability in 
human pluripotent stem cells via no synthase-induced 
oxidative stress. Cells 8, 53. 
Jensen TE, Sylow L, Rose AJ, Madsen AB, Angin Y, Maarbjerg 
SJ & Richter EA (2014). Contraction-stimulated glucose 
transport in muscle is controlled by AMPK and mechanical 
stress but not sarcoplasmatic reticulum Ca2+ release. Mol 
Metab 3, 742–753. 
Johansen KL, Shubert T, Doyle J, Soher B, Sakkas GK & 
Kent-Braun JA (2003). Muscle atrophy in patients receiving 
hemodialysis: effects on muscle strength, muscle quality, and 
physical function. Kidney Int 63, 291–297. 
Kang L, Ayala JE, Lee-Young RS, Zhang Z, James FD, Neufer 
PD, Pozzi A, Zutter MM & Wasserman DH (2011). 
Diet-induced muscle insulin resistance is associated with 
extracellular matrix remodeling and interaction with 
integrin α2β 1in mice. Diabetes 60, 416–426. 
Kang L, Lantier L, Kennedy A, Bonner JS, Mayes WH, Bracy 
DP, Bookbinder LH, Hasty AH, Thompson CB & 
Wasserman DH (2013). Hyaluronan accumulates with 
high-fat feeding and contributes to insulin resistance. 
Diabetes 62, 1888–1896. 
Kang L, Mayes WH, James FD, Bracy DP & Wasserman DH 
(2014). Matrix metalloproteinase 9 opposes diet-induced 
muscle insulin resistance in mice. Diabetologia 57, 603–613. 
Kang L, Mokshagundam S, Reuter B, Lark DS, Sneddon CC, 
Hennayake C, Williams AS, Bracy DP, James FD, Pozzi A, 
Zent R & Wasserman DH (2016). Integrin-linked kinase in 
muscle is necessary for the development of insulin resistance 
in diet-induced obese mice. Diabetes 65, 1590–1600. 
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